Studies find that “there
is evidence from randomized controlled trials that androgen (e.g.,
testosterone) therapy improves the quality of the sexual experience for
postmenopausal women with low libido, and preliminary data that this may
also apply to premenopausal women.” Also, please read:
[ Testosterone-Helps-Female-Libido ] [ Testosterone-Research-Female-Libido ] [ Testosterone-Female-Satisfaction ] [ Why-Women-Dont-Want-Sex ]
Pharmacological therapy for female sexual dysfunction: has progress been
made?
S.R. Davis, E.A. Nijland, Women's Health Program,
Department of Medicine, Monash University, Prahran, Victoria, Australia,
Susan.Davis@med.monash.edu.au,
Drugs. 2008;68(3):259-64
The investigation of female sexual dysfunction (FSD) is
an evolving area in which definitions and models for female sexual
functioning are being continually reviewed and revised. The lack of
consensus amongst experts in the field and regulating authorities regarding
appropriate inclusion and exclusion criteria for FSD trials, and main
outcome measures appropriate for the evaluation of drug interventions has
somewhat hampered progression in this area. Nonetheless, there is evidence
from randomized controlled trials that androgen therapy improves the quality
of the sexual experience for postmenopausal women with low libido, and
preliminary data that this may also apply to premenopausal women.
PMID: 18257605 [PubMed - indexed for MEDLINE]
Also please read:
►New
Testosterone-based gel Livens Up Female Libido
►Transdermal
testosterone improves self-reported sexual satisfaction for
premenopausal women with
reduced libido and low serum-free testosterone.
►Testosterone therapy
improves
female arousability, sexual desire and fantasy, frequency of sexual
activity
and orgasm, and satisfaction and pleasure from the sexual
act. |
